Tivic Health Systems Inc (TIVC)

$0.4

-0.01

(-2.87%)▲

Market is closed - opens 7 PM, 04 Jun 2024

Insights on Tivic Health Systems Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 357.0K → 334.0K (in $), with an average decrease of 6.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -2.24M → -1.48M (in $), with an average increase of 51.5% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 45.7% return, outperforming this stock by 142.0%

Performance

  • $0.39
    $0.42
    $0.40
    downward going graph

    3.75%

    Downside

    Day's Volatility :7.89%

    Upside

    4.31%

    downward going graph
  • $0.35
    $21.75
    $0.40
    downward going graph

    12.88%

    Downside

    52 Weeks Volatility :98.4%

    Upside

    98.16%

    downward going graph

Returns

PeriodTivic Health Systems IncIndex (Russel 2000)
3 Months
-69.23%
0.0%
6 Months
-81.57%
0.0%
1 Year
-96.28%
0.0%
3 Years
-99.92%
-22.6%

Highlights

Market Capitalization
2.5M
Book Value
$1.46
Earnings Per Share (EPS)
-0.89
Wall Street Target Price
210.0
Profit Margin
0.0%
Operating Margin TTM
-443.41%
Return On Assets TTM
-91.58%
Return On Equity TTM
-206.82%
Revenue TTM
1.1M
Revenue Per Share TTM
1.02
Quarterly Revenue Growth YOY
-11.200000000000001%
Gross Profit TTM
-129.0K
EBITDA
-7.6M
Diluted Eps TTM
-0.89
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 52400.0%

Current $0.40
Target $210.00

Company Financials

FY19Y/Y Change
Revenue
420.0K
-
Net Income
-4.1M
-
Net Profit Margin
-987.62%
-
FY20Y/Y Change
Revenue
860.0K
↑ 104.76%
Net Income
-4.1M
↓ 1.71%
Net Profit Margin
-474.07%
↑ 513.55%
FY21Y/Y Change
Revenue
1.2M
↑ 35.58%
Net Income
-8.5M
↑ 108.34%
Net Profit Margin
-728.47%
↓ 254.4%
FY22Y/Y Change
Revenue
1.8M
↑ 57.8%
Net Income
-10.1M
↑ 18.86%
Net Profit Margin
-548.7%
↑ 179.77%
FY23Y/Y Change
Revenue
1.2M
↓ 36.09%
Net Income
-8.2M
↓ 18.34%
Net Profit Margin
-701.02%
↓ 152.32%
Q4 FY22Q/Q Change
Revenue
408.0K
↓ 14.47%
Net Income
-2.3M
↓ 12.7%
Net Profit Margin
-552.7%
↓ 11.19%
Q1 FY23Q/Q Change
Revenue
376.0K
↓ 7.84%
Net Income
-2.1M
↓ 6.16%
Net Profit Margin
-562.77%
↓ 10.07%
Q2 FY23Q/Q Change
Revenue
161.0K
↓ 57.18%
Net Income
-2.1M
↑ 0.43%
Net Profit Margin
-1.3K%
↓ 757.11%
Q3 FY23Q/Q Change
Revenue
282.0K
↑ 75.16%
Net Income
-1.8M
↓ 17.18%
Net Profit Margin
-624.11%
↑ 695.77%
Q4 FY23Q/Q Change
Revenue
357.0K
↑ 26.6%
Net Income
-2.2M
↑ 27.44%
Net Profit Margin
-628.29%
↓ 4.18%
Q1 FY24Q/Q Change
Revenue
334.0K
↓ 6.44%
Net Income
-1.5M
↓ 33.97%
Net Profit Margin
-443.41%
↑ 184.88%
FY19Y/Y Change
Total Assets
3.0M
-
Total Liabilities
653.0K
-
FY20Y/Y Change
Total Assets
1.5M
↓ 49.37%
Total Liabilities
2.7M
↑ 314.7%
FY21Y/Y Change
Total Assets
15.0M
↑ 882.1%
Total Liabilities
1.8M
↓ 34.86%
FY22Y/Y Change
Total Assets
5.9M
↓ 61.05%
Total Liabilities
2.2M
↑ 26.19%
FY23Y/Y Change
Total Assets
5.3M
↓ 10.28%
Total Liabilities
1.7M
↓ 24.8%
Q4 FY22Q/Q Change
Total Assets
5.9M
↓ 28.65%
Total Liabilities
2.2M
↓ 8.62%
Q1 FY23Q/Q Change
Total Assets
7.1M
↑ 21.26%
Total Liabilities
1.9M
↓ 14.82%
Q2 FY23Q/Q Change
Total Assets
4.6M
↓ 35.28%
Total Liabilities
1.4M
↓ 24.31%
Q3 FY23Q/Q Change
Total Assets
7.0M
↑ 52.46%
Total Liabilities
1.2M
↓ 13.45%
Q4 FY23Q/Q Change
Total Assets
5.3M
↓ 25.02%
Total Liabilities
1.7M
↑ 34.78%
Q1 FY24Q/Q Change
Total Assets
3.3M
↓ 37.46%
Total Liabilities
1.1M
↓ 32.32%
FY19Y/Y Change
Operating Cash Flow
-3.7M
-
Investing Cash Flow
-31.0K
-
Financing Cash Flow
5.6M
-
Q4 FY22Q/Q Change
Operating Cash Flow
-2.2M
↓ 19.66%
Investing Cash Flow
-94.0K
↑ 1780.0%
Financing Cash Flow
-584.0K
↓ 1142.86%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.4M
↑ 8.94%
Investing Cash Flow
-94.0K
↑ 0.0%
Financing Cash Flow
4.2M
↓ 814.04%

Technicals Summary

Sell

Neutral

Buy

Tivic Health Systems Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tivic Health Systems Inc
Tivic Health Systems Inc
-61.9%
-81.57%
-96.28%
-99.92%
-99.92%
Stryker Corporation
Stryker Corporation
4.27%
16.65%
22.1%
34.77%
82.03%
Boston Scientific Corp.
Boston Scientific Corp.
4.07%
37.85%
46.89%
79.63%
93.34%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
3.26%
27.0%
2.23%
-8.36%
51.45%
Abbott Laboratories
Abbott Laboratories
-2.62%
-2.21%
-0.86%
-5.87%
32.8%
Medtronic Plc
Medtronic Plc
0.44%
2.96%
-1.92%
-33.69%
-13.02%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tivic Health Systems Inc
Tivic Health Systems Inc
NA
NA
NA
0.0
-2.07
-0.92
NA
1.46
Stryker Corporation
Stryker Corporation
38.89
38.89
2.92
11.96
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.5
63.5
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
37.45
37.45
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
31.83
31.83
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
29.48
29.48
1.52
5.2
0.07
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tivic Health Systems Inc
Tivic Health Systems Inc
NA
$2.5M
-99.92%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$129.9B
82.03%
38.89
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$111.1B
93.34%
63.5
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.4B
51.45%
37.45
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$177.8B
32.8%
31.83
13.96%
Medtronic Plc
Medtronic Plc
Buy
$106.7B
-13.02%
29.48
11.36%

Institutional Holdings

  • Vanguard Group Inc

    0.78%

  • Geode Capital Management, LLC

    0.21%

  • Tower Research Capital LLC

    0.04%

Company Information

the tivic health team is dedicated to exploring the use of microcurrents for therapeutic benefit and pioneering advances in bioelectronic medicine. our initial focus is delivering sinus pain relief. synus is new alternative for temporary relief of sinus pain and pressure. www.tivichealth.com/synus currently, the most recommended treatment for those experiencing recurring sinus pain is daily flushing of the nose with salt water. we believe people should have access to relief without pills, sprays and flushes.

Organization
Tivic Health Systems Inc
Employees
9
CEO
Ms. Jennifer Ernst
Industry
Miscellaneous

Discover More

FAQs